The Journal of Urology
Volume 181, Issue 4 , Pages 1901-1906 , April 2009

Prevention and Treatment of Transitional Cell Carcinomatosis With Intraperitoneal Chemotherapy in a Rat Model

Received 18 July 2008

References 

  1. Irani J, Mottet N, Caparros MJR, Teillac P. New trends in bladder cancer management. Eur Urol, supp. 2007;6:388
  2. Collado A, Chechile GE, Salvador J, Vicente J. Early complications of endoscopic treatment for superficial bladder tumors. J Urol. 2000;164:1529
  3. Mydlo JH, Weinstein R, Shah S, Solliday M, Macchia RJ. Long-term consequences from bladder perforation and/or violation in the presence of transitional cell carcinoma: results of a small series and a review of the literature. J Urol. 1999;161:1128
  4. Abaza R, Keck RW, Selman SH. Intraperitoneal chemotherapy for the prevention of transitional cell carcinoma implantation. J Urol. 2006;175:2317
  5. Jurczok A, Schneider A, Fornara P. Inhibition of tumor implantation after laparoscopy by specific oligopeptides: a novel approach to adjuvant intraperitoneal therapy to prevent tumor implantation in an animal model. Eur Urol. 2007;52:590
  6. Sugarbaker PH. Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol. 1998;14:254
  7. Markman M. Intraperitoneal antineoplastic drug delivery: rationale and results. Lancet Oncol. 2003;4:277
  8. Chakavarti A, Day DW, MacDermott S. Extravesical transitional cell carcinoma as a result of implantation after perforation of the bladder. BJU Int. 2000;85:1150
  9. Yap WT, Ritchie JP. Metastasis from transitional cell carcinoma of the bladder masquerading as psoas abscess. J Urol. 1980;123:959
  10. Breul J, Block T, Breidenbch H, Hartung R. Implantation metastasis after a suprapubic catheter in a case of bladder cancer. Eur Urol. 1992;22:86
  11. Skolarikos A, Chrisofos M, Ferakis N, Papatsoris A, Dellis A, Charalambos D. Does the management of bladder perforation during transurethral resection of superficial bladder tumors predispose to extravesical tumor recurrence?. J Urol. 2005;173:1908
  12. Emmanuel L, Huguet MB, Keeling NJ. Distilled water peritoneal lavage after colorectal cancer surgery. Dis Colon Rectum. 2004;47:2114
  13. Morris PC, Scholten V. Osmotic lysis of tumor spill in ovarian cancer: a murine model. Am J Obstet Gynecol. 1996;175:1489
  14. Hribaschek A, Kuhn R, Pross M, Lippert H, Halangk W, Boltze C, et al. Prophylaxis of peritoneal carcinomatosis in experimental investigations. Int J Colorectal Dis. 2001;16:340
  15. Ost MC, Patel KP, Rastinehad AR, Chu PY, Anderson AE, Smith AD, et al. Pneumoperitoneum with carbon dioxide inhibits macrophage tumor necrosis factor-α secretion: source of transitional-cell carcinoma port-site metastasis, with prophylactic irrigation strategies to decrease laparoscopic oncologic risks. J Endourol. 2008;22:105
  16. Jacquet P, Averbach A, Stephens AD, Stuart OA, Chang D, Sugarbaker PH. Heated intraoperative intraperitoneal mitomycin c and early postoperative intraperitoneal 5-fluorouracil: pharmacokinetic studies. Oncology. 1998;55:130

 Study received University of Toledo institutional animal care and use committee approval.

 Supported by the Frank D. Stranahan Endowment for Oncological Research, Medical University of Ohio Foundation.

PII: S0022-5347(08)03252-7

doi: 10.1016/j.juro.2008.11.089

The Journal of Urology
Volume 181, Issue 4 , Pages 1901-1906 , April 2009

Article Tools

* Image Usage & Resolution